Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gordon L Amidon

Showing results (81-90 of 185) with videos related to

Pageof 19
Sort By:
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|February 4, 2014
The Biopharmaceutics Classification System: subclasses for in vivo predictive dissolution (IPD) methodology and IVIVCYasuhiro Tsume, Deanna M Mudie, Peter Langguth, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|April 25, 2008
Mechanistic understanding of time-dependent oral absorption based on gastric motor activity in humansKazutaka Higaki, Sally Y Choe, Raimar Löbenberg, et al.
Journal of Pharmaceutical Sciences|December 30, 2009
The solubility-permeability interplay in using cyclodextrins as pharmaceutical solubilizers: mechanistic modeling and application to progesteroneArik Dahan, Jonathan M Miller, Amnon Hoffman, et al.
Journal of Pharmaceutical Sciences|February 22, 2025
A new model for ionizable drug dissolution in intestinal bicarbonate bufferJozef Al-Gousous, Adrin Jalali Sohi, Niloufar Salehi, et al.
Journal of Pharmaceutical Sciences|September 19, 2017
The Combination of GIS and Biphasic to Better Predict In Vivo Dissolution of BCS Class IIb Drugs, Ketoconazole and RaloxifeneYasuhiro Tsume, Naoto Igawa, Adam J Drelich, et al.
Drug Metabolism and Pharmacokinetics|March 3, 2007
Characteristics of gastrointestinal absorption of DX-9065a, a new synthetic anticoagulantYoshimine Fujii, Masayuki Takahashi, Hiromi Morita, et al.
Pharmaceutical Research|September 1, 2005
Floxuridine amino acid ester prodrugs: enhancing Caco-2 permeability and resistance to glycosidic bond metabolismChristopher P Landowski, Xueqin Song, Philip L Lorenzi, et al.
Pharmaceutics|December 1, 2020
Erratum: Hens, B.; et al. Application of the Gastrointestinal Simulator (GIS) Coupled with In Silico Modeling to Measure the Impact of Coca-Cola<sup>®</sup> on the Luminal and Systemic Behavior of Loratadine (BCS Class 2b). <i>Pharmaceutics</i>, 2020, <i>12</i>, 566Bart Hens, Marival Bermejo, Patrick Augustijns, et al.
Pharmacological Research|December 17, 2008
Interferon-gamma increases expression of the di/tri-peptide transporter, h-PEPT1, and dipeptide transport in cultured human intestinal monolayersDavid R Foster, Christopher P Landowski, Xiaomei Zheng, et al.
Pharmaceutical Research|April 15, 2011
The BCS, BDDCS, and regulatory guidancesMei-Ling Chen, Gordon L Amidon, Leslie Z Benet, et al.
Pageof 19

Showing results (81-90 of 185) with videos related to

Sort By:
Pageof 19
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|February 4, 2014
The Biopharmaceutics Classification System: subclasses for in vivo predictive dissolution (IPD) methodology and IVIVCYasuhiro Tsume, Deanna M Mudie, Peter Langguth, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|April 25, 2008
Mechanistic understanding of time-dependent oral absorption based on gastric motor activity in humansKazutaka Higaki, Sally Y Choe, Raimar Löbenberg, et al.
Journal of Pharmaceutical Sciences|December 30, 2009
The solubility-permeability interplay in using cyclodextrins as pharmaceutical solubilizers: mechanistic modeling and application to progesteroneArik Dahan, Jonathan M Miller, Amnon Hoffman, et al.
Journal of Pharmaceutical Sciences|February 22, 2025
A new model for ionizable drug dissolution in intestinal bicarbonate bufferJozef Al-Gousous, Adrin Jalali Sohi, Niloufar Salehi, et al.
Journal of Pharmaceutical Sciences|September 19, 2017
The Combination of GIS and Biphasic to Better Predict In Vivo Dissolution of BCS Class IIb Drugs, Ketoconazole and RaloxifeneYasuhiro Tsume, Naoto Igawa, Adam J Drelich, et al.
Drug Metabolism and Pharmacokinetics|March 3, 2007
Characteristics of gastrointestinal absorption of DX-9065a, a new synthetic anticoagulantYoshimine Fujii, Masayuki Takahashi, Hiromi Morita, et al.
Pharmaceutical Research|September 1, 2005
Floxuridine amino acid ester prodrugs: enhancing Caco-2 permeability and resistance to glycosidic bond metabolismChristopher P Landowski, Xueqin Song, Philip L Lorenzi, et al.
Pharmaceutics|December 1, 2020
Erratum: Hens, B.; et al. Application of the Gastrointestinal Simulator (GIS) Coupled with In Silico Modeling to Measure the Impact of Coca-Cola<sup>®</sup> on the Luminal and Systemic Behavior of Loratadine (BCS Class 2b). <i>Pharmaceutics</i>, 2020, <i>12</i>, 566Bart Hens, Marival Bermejo, Patrick Augustijns, et al.
Pharmacological Research|December 17, 2008
Interferon-gamma increases expression of the di/tri-peptide transporter, h-PEPT1, and dipeptide transport in cultured human intestinal monolayersDavid R Foster, Christopher P Landowski, Xiaomei Zheng, et al.
Pharmaceutical Research|April 15, 2011
The BCS, BDDCS, and regulatory guidancesMei-Ling Chen, Gordon L Amidon, Leslie Z Benet, et al.
Pageof 19